Antisense oligonucleotide therapy
Term · Oncology and biomedicine · MLC-T-ONC-000649
Treatment with antisense oligonucleotides. These are small pieces of DNA or RNA that can bind to specific molecules of RNA. This blocks the cell’s ability to use the RNA to make a protein or work in other ways. Antisense oligonucleotides are being studied in the treatment of many types of cancer. Also called antisense therapy.
| Identifier | MLC-T-ONC-000649 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | antisense therapy |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000649",
"term": "Antisense oligonucleotide therapy",
"field": "Oncology and biomedicine",
"definition": "Treatment with antisense oligonucleotides. These are small pieces of DNA or RNA that can bind to specific molecules of RNA. This blocks the cell’s ability to use the RNA to make a protein or work in other ways. Antisense oligonucleotides are being studied in the treatment of many types of cancer. Also called antisense therapy.",
"synonyms": [
"antisense therapy"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/antisense-oligonucleotide-therapy/"
}
Record 2,226 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.